Ricardo Ruiz-Villaverde

162PUBLICATIONS
136CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyNeonatologyNanotoxicology, health and safetyAllergyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (162)

|Aug 19, 2026
Oral Roflumilast in Lichen Planus: A Prospective Real-World Case Series of Ten Adults.

|Jun 22, 2026
ACOX1 Gain-of-Function and De Novo ROBO1 Variant in ACOX1-sEDD.

|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).

|May 27, 2026
Efficacy and Safety of Guselkumab in Real-World Evidence: A Systematic Review and Meta-Analysis.

|Apr 14, 2026
Mogamulizumab-Induced Linear IgA Bullous Dermatosis in a Patient With Sézary Syndrome.

María Zulaika-Lloret, David Moyano-Bueno, Ricardo Ruiz-Villaverde

|Mar 31, 2026
Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Joan Ceravalls, Ignasi Figueras-Nart, Javier Melgosa Ramos

Pageof 27

Frequent Collaborators

51 joint publications

Francisco Navarro-Triviño

21 joint publications

Álvaro Prados-Carmona

12 joint publications

Teresa Rodenas-Herranz

10 joint publications

José-Juan Pereyra-Rodriguez